A cross-sectional study to explore depression in postmenopausal women

Fatima Khurshid; Ahmed Nawaz Chatta; Mohammed Zain; Hina Aziz; Tanzeela Khalil Dar; Irum Saghir

doi:10.32593/jstmu/Vol7.Iss1.299

Fatima Khurshid Department of Medicine, Mohi-ud-Din Teaching Hospital, Mirpur AJK, Pakistan
Ahmed Nawaz Chatta Pak Red Crescent Medical and Dental College, Lahore. Pakistan
Mohammed Zain Department of Health Card office, State Life Islamabad, Pakistan
Hina Aziz Department of Medicine, Fatima Jinnah Medical University, Lahore, Pakistan
Tanzeela Khalil Dar Department of Medicine, Pakistan Airforce Hospital, Islamabad, Pakistan
Irum Saghir World Health Organization, Mirpur AJK, Pakistan

DOI: https://doi.org/10.32593/jstmu/Vol7.Iss1.299

Keywords: Menopausal symptoms, Menopausal Rating Scale,, Anxiety, Depression, Menopause

Abstract

Introduction: The impact of depression on postmenopausal women is a significant public health concern but remains largely unknown. Menopause signifies the cessation of a woman’s reproductive ability, indicating the halt of ovarian activity and leading to permanent amenorrhea. This organic change is associated with various symptoms including physical, vasomotor, sexual, and psychological elements. This cross-sectional survey was conducted to investigate the severity of depression in postmenopausal women and the factors that influence that depression.

Methodology: This study examined 240 women from the Gynae department of DHQ Hospital Mirpur, AJK, Pakistan. Data on menopausal symptoms and demographic traits was collected via structured interviews and Menopausal Rating Scale (MRS) questionnaires.

Results: The study revealed that 57% of participants experienced physiological symptoms such as hot flashes, sweating, heart discomfort, insomnia, and sleep problems. Psychologically, 39% experienced depressive mood, irritability, anxiety, and exhaustion. Urogenital, 60% experienced sexual problems, bladder issues, and vagina dryness. The severity of symptoms varied, with 5% reporting no symptoms, 77% reporting mild to moderate symptoms, and 18% reporting severe to extremely severe symptoms.

Conclusion: The study reveals that postmenopausal women often experience mild to moderate depression symptoms, emphasizing the need for personalized support and interventions to enhance their overall well-being.

Downloads

Download data is not yet available.

Author Biographies

Fatima Khurshid, Department of Medicine, Mohi-ud-Din Teaching Hospital, Mirpur AJK, Pakistan

Medical Doctor

Ahmed Nawaz Chatta, Pak Red Crescent Medical and Dental College, Lahore. Pakistan

MBBS Student

Mohammed Zain, Department of Health Card office, State Life Islamabad, Pakistan

District Medical Officer

Hina Aziz, Department of Medicine, Fatima Jinnah Medical University, Lahore, Pakistan

Medical Graduate

Tanzeela Khalil Dar, Department of Medicine, Pakistan Airforce Hospital, Islamabad, Pakistan

Medical Officer

Irum Saghir, World Health Organization, Mirpur AJK, Pakistan

Disease Surveillance Officer

References

Wang X, Zhao G, Di J, Wang L, Zhang X. Prevalence and risk factors for depressive and anxiety symptoms in middle-aged Chinese women: a community-based cross-sectional study. BMC Womens Health. 2022; 22(1):319.

DOI: https://doi.org/10.1186/s12905-022-01908-6.

Ahmadi N, Delavar MA, Mashayekh-Amiri S, Esmaeilzadeh S. Exploring the relationship between depression on menopausal symptoms and personality trails. Com Healt Equity Res Policy. 2023; 43(2):125-31.

DOI: https://doi.org/10.1177/0272684X211004926.

Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, et al. Executive summary of the Stages of Reproductive Aging Workshop+ 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 2012; 97(4):1159-68.

DOI: https://doi.org/10.1210/jc.2011-3362

Papazisis G, Tsakiridis I, Ainatzoglou A, Pappa A, Bellali T, Kouvelas D, Dagklis T. Prevalence of post-menopausal depression and associated factors: A web-based cross-sectional study in Greece. Maturitas. 2022; 156:12-7.

DOI: https://doi.org/10.1016/j.maturitas.2021.10.014.

Di Benedetto MG, Landi P, Mencacci C, Cattaneo A. Depression in Women: Potential Biological and Sociocultural Factors Driving the Sex Effect. Neuropsychobiology. 2024; 83(1):2-16.

DOI: https://doi.org/10.1159/000531588

Nappi RE, Siddiqui E, Todorova L, Rea C, Gemmen E, Schultz NM. Prevalence and quality-of-life burden of vasomotor symptoms associated with menopause: A European cross-sectional survey. Maturitas. 2023; 167:66-74.

DOI: https://doi.org/10.1016/j.maturitas.2022.09.006.

Mulhall S, Anstey K. Prevalence and severity of menopausal symptoms in a population-based sample of midlife women. Innovat Aging. 2018; 2(Suppl 1):711.

DOI: https://doi.org/10.1093/geroni/igy023.2635

Fenton A, Panay N. Menopause and the workplace. Climacteric. 2014; 17(4):317-8.

DOI: https://doi.org/10.3109/13697137.2014.932072.

Burden L. Women are leaving the workforce for a little-talked-about reason. Bloomberg UK. 2021; 18.

Kuck MJ, Hogervorst E. Stress, depression, and anxiety: psychological complaints across menopausal stages. Front Psychiatry. 2024; 15:1323743.

DOI: https://doi.org/10.3389/fpsyt.2024.1323743.

De Villiers T. The management of vasomotor symptoms of menopause (VMS) with menopausal hormone therapy (MHT). Curr Opin Endocr Metab Res. 2022; 27:100420.

Hamoda H, Panay N, Pedder H, Arya R, Savvas M. The British Menopause Society & Women’s Health Concern 2020 recommendations on hormone replacement therapy in menopausal women. Post Reprod Health. 2020; 26(4):181-209.

DOI: https://doi.org/10.1177/2053369120957514.

Alblooshi S, Taylor M, Gill N. Does menopause elevate the risk for developing depression and anxiety? Results from a systematic review. Australas Psychiatry. 2023; 31(2):165-73.

DOI: https://doi.org/10.1177/10398562231165439.

Willi J, Ehlert U. Assessment of perimenopausal depression: a review. J Affect Disord. 2019; 249:216-22.

DOI: https://doi.org/10.1016/j.jad.2019.02.029.

Weidner K, Bittner A, Beutel M, Goeckenjan M, Brähler E, Garthus-Niegel S. The role of stress and self-efficacy in somatic and psychological symptoms during the climacteric period–Is there a specific association?. Maturitas. 2020; 136:1-6.

DOI: https://doi.org/10.1016/j.maturitas.2020.03.004.

Lee J, Lee JE. Psychological well-being of midlife women: a structural equation modeling approach. Menopause. 2022; 29(4):440-9.

DOI: https://doi.org/10.1097/GME.0000000000001933.

García-León MÁ, Pérez-Mármol JM, Gonzalez-Pérez R, del Carmen García-Ríos M, Peralta-Ramírez MI. Relationship between resilience and stress: Perceived stress, stressful life events, HPA axis response during a stressful task and hair cortisol Physiol Behav. 2019; 202:87-93.

DOI: https://doi.org/10.1016/j.physbeh.2019.02.001.

Hedgeman E, Hasson RE, Karvonen-Gutierrez CA, Herman WH, Harlow SD. Perceived stress across the midlife: longitudinal changes among a diverse sample of women, the Study of Women’s health Across the Nation (SWAN). Women Midlife Heal. 2018; 4:1-1.

DOI: https://doi.org/10.1186/s40695-018-0032-3.

Heinemann K, Ruebig A, Potthoff P, Schneider HP, Strelow F, Heinemann LA, Thai DM. The Menopause Rating Scale (MRS) scale: a methodological review. Health Qual Life Outcomes. 2004; 2:1-8.

DOI: https://doi.org/10.1186/1477-7525-2-45.

Masjoudi M, Amjadi MA, Leyli EK. Severity and frequency of menopausal symptoms in middle aged women, Rasht, Iran. J Clin Diagn Res. 2017; 11(8):QC17.

DOI: https://doi.org/10.7860/JCDR/2017/26994.10515.

Chuni N, Sreeramareddy CT. Frequency of symptoms, determinants of severe symptoms, validity of and cut-off score for Menopause Rating Scale (MRS) as a screening tool: a cross-sectional survey among midlife Nepalese women. BMC Women Health. 2011; 11:1-9.

DOI: https://doi.org/10.1186/1472-6874-11-30.

Ceylan B, Özerdoğan N. Menopausal symptoms and quality of life in Turkish women in the climacteric period. Climacteric. 2014; 17(6):705-12.

DOI: https://doi.org/10.3109/13697137.2014.929108.

Poomalar GK, Arounassalame B. The quality of life during and after menopause among rural women. J Clin Diagn Res. 2013; 7(1):135.

DOI: https://doi.org/10.7860/JCDR/2012/4910.2688.

Blümel JE, Arteaga E, Parra J, Monsalve C, Reyes V, Vallejo MS, et al. Decision-making for the treatment of climacteric symptoms using the Menopause Rating Scale. Maturitas. 2018; 111:15-9.

DOI: https://doi.org/10.1016/j.maturitas.2018.02.010.